Aclarion, Inc.
ACON
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $1.3M
$2.35
▲ +2.62%
P/E
—
Mkt Cap
$1.3M
52-Wk Range
$1.95–$12.03
52-Week Range
$1.95 - $12.03
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 66.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary MRS software technology for pain biomarker detection
- First-mover advantage in objective degenerative pain quantification
- Clinical decision support integration reducing diagnostic variability
- Specialized expertise in magnetic resonance spectroscopy imaging
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Growing demand for objective pain measurement in healthcare
Value
Valuation data unavailable
Momentum
Falling
-30.1% over 3m
Quality
Loss-making
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying ACON right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 6, 2026
Reported EPS of -$1.12 vs -$1.05 consensus (-6.7% surprise). Revenue of $25.2K vs $30.0K expected (-16.0%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-6.7%
Revenue trend · last 8Q
—
—
+88%
+76%
+31%
+81%
+11%
+30%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$14.4K
$10.2K
$19.0K
$19.3K
$18.9K
$18.5K
$21.1K
$25.2K
Margins · last 8Q
Gross
32.9%
Profit
-10899.5%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ascendiant Capital · May 29, 2026
vs Industry
How ACON stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related